Filing Details

Accession Number:
0001181431-14-007497
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-18 20:40:02
Reporting Period:
2014-02-13
Filing Date:
2014-02-18
Accepted Time:
2014-02-18 20:40:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
878526 Natus Medical Inc BABY Electromedical & Electrotherapeutic Apparatus (3845) 770154833
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1247930 A Robert Gunst C/O Natus Medical Incorporated
1501 Industrial Road
San Carlos CA 94070
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Per Share Acquisiton 2014-02-13 12,500 $5.77 61,750 No 4 M Direct
Common Stock, $0.001 Par Value Per Share Disposition 2014-02-13 12,500 $25.00 49,250 No 4 S Direct
Common Stock, $0.001 Par Value Per Share Acquisiton 2014-02-14 5,000 $20.09 54,250 No 4 M Direct
Common Stock, $0.001 Par Value Per Share Disposition 2014-02-14 5,000 $25.00 49,250 No 4 S Direct
Common Stock, $0.001 Par Value Per Share Disposition 2014-02-14 2,500 $25.00 46,750 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Options Disposition 2014-02-13 12,500 $5.77 12,500 $5.77
Common Stock Non-Qualified Stock Options Disposition 2014-02-14 5,000 $20.09 5,000 $20.09
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2004-07-11 2014-06-11 No 4 M Direct
0 2008-07-10 2014-07-10 No 4 M Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $25.00 to $25.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.